Why is the UK subscription model for antibiotics considered successful?

Lancet Microbe. 2023 Nov;4(11):e852-e853. doi: 10.1016/S2666-5247(23)00250-1. Epub 2023 Aug 22.

Authors

Rebecca E Glover¹, Andrew Singer², Adam P Roberts³, Claas Kirchhelle⁴

Affiliations

¹ Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London WC1H 9SH, UK. Electronic address: Rebecca.Glover@lshtm.ac.uk.
² UK Centre for Ecology & Hydrology, Wallingford, UK.
³ Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
⁴ Department of History, University College Dublin, Dublin, Ireland.

PMID: 37625429
DOI: 10.1016/S2666-5247(23)00250-1

No abstract available

MeSH terms

Anti-Bacterial Agents* / therapeutic use
United Kingdom

Substances

Anti-Bacterial Agents